BioCareSD is the original specialty distributor, known for outstanding customer service. We feature an ever-expanding portfolio of specialty products in hemotology, immunology, neurology, orphan and other ultra-rare disease states.
May 2023 PRODUCT CATALOG
We have extremely agile and wide-reaching distribution capabilities to support our partners and their patients when they need it most.
We are dedicated to helping our customers save lives —one patient, one product and one promise at a time. BioCareSD, a BioCare Company, is one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field-based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We feature an ever-expanding portfolio of specialty products for hematology, thrombophilia, immunology, neurology, ophthalmology, orphan and other ultra-rare diseases. BioCareSD is an Authorized Distributor of Record for all the manufacturers we represent, so you can depend on the quality of our products. We believe that trusted partnerships are pivotal to supporting patients needs. We are proud to support our partners in their mission to save lives. We are always at your service.
We will do whatever it takes to provide our partners with unmatched service-levels.
There is always a live BioCareSD® Team member to answer your calls 24/7/365.
Our distribution network is within a 6 hour delivery window.
Celebrating Over
Outstanding customer service is who we are. We are people who care.
in Specialty Distribution
3
May 2023
BioCareSD In the News...
The BioCare team celebrates and recognizes the following holidays and events this month. ASIAN AMERICAN PACIFIC ISLANDER MONTH MENTAL HEALTH AWARENESS MONTH May 6, 2023 NATIONAL NURSES DAY May 14, 2023 MOTHER’S DAY May 29, 2023 MEMORIAL DAY
BioCareSD and AllyRetina GPO Partner to Help Retina Providers Improve Patient Care and Increase Efficiency BioCareSD announced its partnership with AllyRetina. AllyRetina will serve its GPO members through its physician leadership, a seasoned management team, and innovative tools and technology. Read More
We partner with our customers to deliver the best possible care to patients all over the country. We spare no effort to ensure every customer has, on hand, the inventory they need, when they need it and that there is always a live voice at the other end of the line when duty calls. It is our promise to deliver unparalleled service to our partners and their patients. At the end of every journey there is a patient waiting for life-saving therapeutics. We are people who care.
Seven Things You Need To Know To Successfully Scale Your Privately-Owned Company
The process of scaling your business can seem daunting, but with the right considerations and strategies, it can be navigated with confidence and efficiency. Here are seven tips to help you before, during and after your scale changes. Read More
Visit our News & Insights page for the latest BioCare case studies, news stories, and industry insights.
FOLLOW US
VIEW NEWS & INSIGHTS
5
Product Catalog
ASCENIV™ is the only IVIG produced from blending RSV plasma and normal source plasma 1
Learn More About ASCENIV and the ADvantage Ig Patient Support Program at ASCENIV.com
Indication ASCENIV (immune globulin intravenous, human – slra) is a 10% immune globulin liquid for intravenous injection, indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). PI includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID). Contraindications ASCENIV is contraindicated in: • Patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. • IgA-deficiency patients with antibodies to IgA and a history of hypersensitivity. Warnings and Precautions Severe hypersensitivity reactions may occur with IGIV products, including ASCENIV. In case of hypersensitivity, discontinue ASCENIV infusion immediately and institute appropriate treatment. Patients with known antibodies to IgA may have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with immunoglobulin products and in the absence of known risk factors. Consider baseline assessment of blood viscosity in patients at risk for hyperviscosity and ensure adequate hydration before administration. For patients at risk of thrombosis, administer ASCENIV at the minimum dose and infusion rate practicable. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity. Acute renal dysfunction/failure, osmotic nephrosis, and death may occur upon use of human IGIV products. Ensure that patients are not volume depleted before administering ASCENIV. Periodic monitoring of renal function and urine output is particularly important in patients judged to be at increased risk of developing acute renal failure. Assess renal function, including measurement of blood urea nitrogen (BUN) and serum creatinine, before the initial infusion of ASCENIV and at appropriate intervals thereafter. Discontinue ASCENIV if renal function deteriorates. In at risk patients, administer ASCENIV at the minimum infusion rate practicable. Hyperproteinemia, increased serum viscosity, and hyponatremia or pseudohyponatremia may occur in patients receiving IGIV treatment, including ASCENIV. It is critical to clinically distinguish true hyponatremia from a pseudohyponatremia that is associated with or causally related to hyperproteinemia. Treatment aimed at decreasing serum free water in patients with pseudohyponatremia may lead to volume depletion, a further increase in serum viscosity, and a possible predisposition to thrombotic events. Aseptic meningitis syndrome (AMS) may occur with IGIV treatments, including ASCENIV. AMS usually begins within several hours to 2 days following IGIV treatment. AMS may occur more frequently in association with high doses (2 g/kg) and/or rapid infusion of IGIV. Conduct a thorough neurological examination on patients exhibiting signs and symptoms of AMS, including cerebrospinal fluid (CSF) studies, to rule out other causes of meningitis. IGIV products, including ASCENIV, may contain blood group antibodies that can act as hemolysins and induce in vivo coating of red blood cells (RBCs) with immunoglobulin, causing a positive direct antiglobulin reaction and hemolysis. Monitor patients for clinical signs and symptoms of hemolysis, including appropriate confirmatory laboratory testing. Non-cardiogenic pulmonary edema may occur with IV administered IG. Monitor patients for pulmonary adverse reactions. If suspected, perform appropriate tests for presence of anti-neutrophil in both product and patient serum. May be managed using oxygen therapy with adequate ventilatory support. Because ASCENIV is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. All infections suspected by a physician to possibly have been transmitted by this product should be reported to ADMA Biologics at (1-800-458-4244) . After infusion of immunoglobulin, the transitory rise of the various passively transferred antibodies in the patient’s blood may yield positive serological testing results, with the potential for misleading interpretation. Passive transmission of antibodies to erythrocyte antigens (e.g., A, B, and D) may cause a positive direct or indirect antiglobulin (Coombs’) test. Adverse Reactions The most common adverse reactions to ASCENIV ( ≥ 5% of study subjects) were headache, sinusitis, diarrhea, gastroenteritis viral, nasopharyngitis, upper respiratory tract infection, bronchitis, and nausea.
1. Data on File, ADMA Biologics. IT’S WHAT’S INSIDE THAT COUNTS For patients with primary humoral immunodeficiency (PI)
www.asceniv.com
Focused on what matters most: safety, quality, and efficacy
Important Safety Information for ASCENIV™ WARNING: THROMBOSIS, RENAL DYSFUNCTION AND ACUTE RENAL FAILURE
Thrombosis may occur with immune globulin intravenous (IGIV) products, including ASCENIV. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors. Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of Immune Globulin Intravenous (Human) (IGIV) products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. ASCENIV does not contain sucrose. For patients at risk of thrombosis, renal dysfunction or renal failure, administer ASCENIV at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.
You are encouraged to report side effects of prescription drugs to ADMA Biologics @ 1-800-458-4244 or the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088. For additional safety information about ASCENIV, please see full Prescribing Information.
© 2023 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics. Visit admabiologics.com
AP ALBUMIN PRODUCTS Product Name Package Size
HP HEMATOLOGY PRODUCTS Product Name Package Size
Product Category
NDC # Presentation Product Category
Subcategory
Derivation
Manufacturer
NDC # Presentation
Subcategory
Derivation
Manufacturer
ALBUMIN/PLASMA PROTEIN FRACTION
ANTI-INHIBITOR COAGULANT COMPLEX
ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL
ALBURX
25% 50mL
44206-0251-05
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
FEIBA
1000 IU
64193-0424-02
VIAL
INHIBITORS
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ALBURX
25% 100mL
44206-0251-10
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
FEIBA
2000 IU
64193-0425-02
VIAL
INHIBITORS
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ALBURX
5% 250mL
44206-0310-25
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
ALBURX
5% 500mL
44206-0310-50
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
FEIBA
500 IU
64193-0426-02
VIAL
INHIBITORS
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ALBUTEIN
5% 250mL
68516-5214-01
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
HEMLIBRA
30 MG
50242-0920-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
5% 500mL
68516-5214-02
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
HEMLIBRA
60 MG
50242-0921-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
5% 50mL
68516-5214-05
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
ALBUTEIN
25% 50mL
68516-5216-01
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
HEMLIBRA
105 MG
50242-0922-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
25% 100mL
68516-5216-02
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
HEMLIBRA
150 MG
50242-0923-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
25% 20mL
68516-5216-05
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
ANTITHROMBIN
25% 25 GM / 100 ML
ALBUTEIN FLEXBAG
68516-5216-00
5 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
ALBUTEIN FLEXBAG
5% 500mL
68516-5214-00
2 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
THROMBATE III
500 IU
13533-0602-50
VIAL
COAGULANT ANTITHROMBIN
PLASMA
GRIFOLS USA, LLC
ALBUTEIN FLEXBAG
5% 250mL
68516-5214-09
4 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
THROMBATE III
500 IU
13533-0606-12
VIAL
COAGULANT ANTITHROMBIN
PLASMA
GRIFOLS USA, LLC
25% 12.5 GM / 50 ML
ALBUTEIN FLEXBAG
68516-5216-09
5 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
FACTOR I
ALBUKED
5% 250mL
76125-0790-25
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
FIBRYGA
1 GRAM
68982-0347-01
VIAL
COAGULANT
FACTOR I
PLASMA
OCTAPHARMA USA
ALBUKED
5% 50mL
76125-0790-05
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
RIASTAP
1000 IU
63833-0891-51
VIAL
COAGULANT
FACTOR I
PLASMA
CSL BEHRING LLC
ALBUKED
25% 100 mL
76125-0792-10
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
FACTOR IX
ALBUKED
25% 20mL
76125-0792-20
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
ALBUKED
25% 50 mL
76125-0792-25
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
ALPHANINE
500 IU
68516-3610-02
VIAL
COAGULANT
FACTOR IX
PLASMA
GRIFOLS USA, LLC
ALBUMIN
5% 250mL
68982-0623-02
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPHANINE
1000 IU
68516-3611-02
VIAL
COAGULANT
FACTOR IX
PLASMA
GRIFOLS USA, LLC
ALBUMIN
5% 500mL
68982-0623-03
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPHANINE
1500 IU
68516-3612-02
VIAL
COAGULANT
FACTOR IX
PLASMA
GRIFOLS USA, LLC
ALBUMIN
5% 100mL
68982-0623-01
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
500 IU
71104-0911-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
SANOFI GENZYME
ALBUMIN
20% 50mL
68982-0633-01
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
1000 IU
71104-0922-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
SANOFI GENZYME
ALBUMIN
20% 100mL
68982-0633-02
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALBUMIN
25% 50mL
68982-0643-01
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
2000 IU
71104-0933-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
SANOFI GENZYME
ALBUMIN
25% 100mL
68982-0643-02
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
3000 IU
71104-0944-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
SANOFI GENZYME
FLEXBUMIN
25% 50mL
00944-0493-01
BAG
ALBUMIN
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC. PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC. PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ALPROLIX
250 IU
71104-0966-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
SANOFI GENZYME
FLEXBUMIN
25% 100mL
00944-0493-02
BAG
ALBUMIN
ALPROLIX
4000 IU
71104-0977-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
SANOFI GENZYME
FLEXBUMIN
5% 250mL
00944-0495-05
BAG
ALBUMIN
11
HP HEMATOLOGY PRODUCTS Product Name Package Size
HP HEMATOLOGY PRODUCTS Product Name Package Size
Product Category
Product Category
NDC # Presentation
Subcategory
Derivation
Manufacturer
NDC # Presentation
Subcategory
Derivation
Manufacturer
FACTOR IX COMPLEX FACTOR IX COMPLEX FACTOR IX COMPLEX
BENEFIX RT
250 IU
58394-0633-03
VIAL
COAGULANT
FACTOR IX RECOMBINANT
PFIZER, INC.
PROFILNINE
500 IU
68516-3210-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
BENEFIX RT
500 IU
58394-0634-03
VIAL
COAGULANT
FACTOR IX RECOMBINANT
PFIZER, INC.
PROFILNINE
1000 IU
68516-3211-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
BENEFIX RT
1000 IU
58394-0635-03
VIAL
COAGULANT
FACTOR IX RECOMBINANT
PFIZER, INC.
PROFILNINE
1500 IU
68516-3212-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
FACTOR VIIA
BENEFIX RT
2000 IU
58394-0636-03
VIAL
COAGULANT
FACTOR IX RECOMBINANT
PFIZER, INC.
BENEFIX RT
3000 IU
58394-0637-03
VIAL
COAGULANT
FACTOR IX RECOMBINANT
PFIZER, INC.
NOVOSEVEN RT
1 MG
00169-7201-01
VIAL
INHIBITORS
FACTOR VIIA RECOMBINANT
NOVO NORDISK INC.
IDELVION
250 IU
69911-0864-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT
CSL BEHRING LLC
NOVOSEVEN RT
2 MG
00169-7202-01
VIAL
INHIBITORS
FACTOR VIIA RECOMBINANT
NOVO NORDISK INC.
IDELVION
500 IU
69911-0865-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT
CSL BEHRING LLC
NOVOSEVEN RT
5 MG
00169-7205-01
VIAL
INHIBITORS
FACTOR VIIA RECOMBINANT
NOVO NORDISK INC.
IDELVION
1000 IU
69911-0866-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT
CSL BEHRING LLC
NOVOSEVEN RT
8 MG
00169-7208-01
VIAL
INHIBITORS
FACTOR VIIA RECOMBINANT
NOVO NORDISK INC.
IDELVION
2000 IU
69911-0867-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT
CSL BEHRING LLC
SEVENFACT
1MG
71127-1000-01
VIAL
INHIBITORS
FACTOR VIIA RECOMBINANT
HEMA BIOLOGICS
IDELVION
3500 IU
69911-0869-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT
CSL BEHRING LLC
SEVENFACT
5MG
71127-5000-01
VIAL
INHIBITORS
FACTOR VIIA RECOMBINANT
HEMA BIOLOGICS
FACTOR VIII
REBINYN
1000 IU
00169-7901-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
NOVO NORDISK INC.
REBINYN
2000 IU
00169-7902-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
NOVO NORDISK INC.
ADVATE
1801 IU - 2400 IU 00944-3045-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
REBINYN
500 IU
00169-7905-01
VIAL
COAGULANT
FACTOR IX RECOMBINANT
NOVO NORDISK INC.
ADVATE
2401 IU - 3600 IU 00944-3046-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
250 IU
00944-3026-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
3601 IU - 4800 IU 00944-3047-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
500 IU
00944-3028-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
200 IU - 400 IU 00944-3051-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
1000 IU
00944-3030-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
401 IU - 800 IU 00944-3052-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
2000 IU
00944-3032-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
801 IU - 1200 IU 00944-3053-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
3000 IU
00944-3034-02
VIAL
COAGULANT
FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
1201 IU - 1800 IU 00944-3054-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
FACTOR IX COMPLEX
ADYNOVATE
401 IU - 800 IU 00944-4623-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
FACTOR IX COMPLEX FACTOR IX COMPLEX FACTOR IX COMPLEX FACTOR IX COMPLEX FACTOR IX COMPLEX
KCENTRA
500 IU
63833-0386-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
ADYNOVATE
801 IU - 1250 IU 00944-4624-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
KCENTRA
1000 IU
63833-0387-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
ADYNOVATE
1801-2500 IU 00944-4625-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
PROFILNINE
500 IU
68516-3207-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
ADYNOVATE
750 IU
00944-4626-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
PROFILNINE
1000 IU
68516-3208-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
ADYNOVATE
1500 IU
00944-4627-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADYNOVATE
3000 IU
00944-4628-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
PROFILNINE
1500 IU
68516-3209-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
13
HP HEMATOLOGY PRODUCTS Product Name Package Size
HP HEMATOLOGY PRODUCTS Product Name Package Size
Product Category
Product Category
NDC # Presentation
Subcategory
Derivation
Manufacturer
NDC # Presentation
Subcategory
Derivation
Manufacturer
AFSTYLA
250 IU
69911-0474-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
HEMOFIL
401 IU – 800 IU 00944-3942-02
VIAL
COAGULANT
FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
500 IU
69911-0475-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
HEMOFIL
801 IU – 1200 IU 00944-3944-02
VIAL
COAGULANT
FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
1000 IU
69911-0476-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
HEMOFIL
1201 IU – 2000 IU 00944-3946-02
VIAL
COAGULANT
FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
2000 IU
69911-0477-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
500 IU
00026-3942-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
AFSTYLA
3000 IU
69911-0478-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
1000 IU
00026-3944-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
AFSTYLA
1500 IU
69911-0480-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
2000 IU
00026-3946-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
AFSTYLA
2500 IU
69911-0481-02
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
3000 IU
00026-3948-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ALTUVIIIO
250 IU
71104-0978-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOATE
250 IU
76125-0257-25
VIAL
COAGULANT
FACTOR VIII
PLASMA
KEDRION BIOPHARMA
ALTUVIIIO
500 IU
71104-0979-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOATE
500 IU
76125-0663-50
VIAL
COAGULANT
FACTOR VIII
PLASMA
KEDRION BIOPHARMA
ALTUVIIIO
1000 IU
71104-0981-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOATE
1000 IU
76125-0676-50
VIAL
COAGULANT
FACTOR VIII
PLASMA
KEDRION BIOPHARMA
ALTUVIIIO
2000 IU
71104-0982-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
250 IU
00026-3782-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ALTUVIIIO
3000 IU
71104-0983-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
500 IU
00026-3783-35
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ALTUVIIIO
4000 IU
71104-0984-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
1000 IU
00026-3785-55
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
250 IU
71104-0801-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
2000 IU
00026-3786-65
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
500 IU
71104-0802-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
3000 IU
00026-3787-75
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
700 IU
71104-0803-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
250 IU
00026-3821-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
1000 IU
71104-0804-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
500 IU
00026-3822-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
1500 IU
71104-0805-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
1000 IU
00026-3824-25
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
2000 IU
71104-0806-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
2000 IU
00026-3826-50
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
3000 IU
71104-0807-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
3000 IU
00026-3828-50
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
BAYER CORPORATION
ELOCTATE
4000 IU
71104-0808-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
NOVOEIGHT
1000 IU
00169-7810-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
ELOCTATE
5000 IU
71104-0809-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
NOVOEIGHT
1500 IU
00169-7815-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
ELOCTATE
6000 IU
71104-0810-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
SANOFI GENZYME
NOVOEIGHT
2000 IU
00169-7820-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
ESPEROCT
1000 IU
00169-8100-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
NOVOEIGHT
250 IU
00169-7825-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
ESPEROCT
1500 IU
00169-8150-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
NOVOEIGHT
3000 IU
00169-7830-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
ESPEROCT
2000 IU
00169-8200-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
NOVOEIGHT
500 IU
00169-7850-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
ESPEROCT
3000 IU
00169-8300-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
NUWIQ
250 IU
68982-0139-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ESPEROCT
500 IU
00169-8500-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
NUWIQ
500 IU
68982-0141-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
HEMOFIL
220 IU – 400 IU 00944-3940-02
VIAL
COAGULANT
FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
NUWIQ
1000 IU
68982-0143-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
15
HP HEMATOLOGY PRODUCTS Product Name Package Size
HP HEMATOLOGY PRODUCTS Product Name Package Size
Product Category
Product Category
NDC # Presentation
Subcategory
Derivation
Manufacturer
NDC # Presentation
Subcategory
Derivation
Manufacturer
FACTOR VIII WITH VON WILLEBRAND FACTOR
NUWIQ
1500 IU
68982-0153-01
Vial
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF
ALPHANATE
250 IU
68516-4611-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
2000 IU
68982-0145-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
250 IU
68516-4616-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
2500 IU
68982-0147-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
500 IU
68516-4617-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
3000 IU
68982-0149-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
1000 IU
68516-4618-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
4000 IU
68982-0151-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
1500 IU
68516-4619-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
OBIZUR
1-PACK 500 AU 00944-5001-01
VIAL
INHIBITORS
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ALPHANATE
2000 IU
68516-4620-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
OBIZUR-RECOMBINANT FACTOR VIII SUBSTRATE 1 CARTON = 1 VIAL
1505746
VIAL
INHIBITORS
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
HUMATE-P
600 RCOF
63833-0615-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
HUMATE-P
1200 RCOF
63833-0616-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
TRETTEN
2000 IU - 3125 IU 00169-7013-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
NOVO NORDISK INC.
HUMATE-P
2400 RCOF
63833-0617-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
RECOMBINATE
220 IU – 400 IU 00944-2841-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
WILATE
500 RCOF
68982-0182-01
VIAL
COAGULANT
PLASMA
OCTAPHARMA USA
RECOMBINATE
401 IU – 800 IU 00944-2842-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
WILATE
1000 RCOF
68982-0182-02
VIAL
COAGULANT
PLASMA
OCTAPHARMA USA
RECOMBINATE
801 IU – 1240 IU 00944-2843-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
FACTOR X
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
RECOMBINATE
1241-1800 IU 00944-2844-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
COAGADEX
250 IU
64208-7752-01
VIAL
COAGULANT
FACTOR X
PLASMA
COAGADEX
500 IU
64208-7753-01
VIAL
COAGULANT
FACTOR X
PLASMA
RECOMBINATE
1801 – 2400 IU 00944-2845-10
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
FACTOR XA
XYNTHA
250 IU
58394-0012-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
CARTON: 4 VIALS/CTN COAGULANT
ANDEXXA
200 MG VIAL
69853-0102-01
FACTOR XA RECOMBINANT
ALEXION
XYNTHA
500 IU
58394-0013-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
FACTOR XIII
CORIFACT
1000 IU
63833-0518-02
VIAL
COAGULANT
FACTOR XIII
PLASMA
CSL BEHRING LLC
XYNTHA
1000 IU
58394-0014-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
VON WILLEBRAND FACTOR
XYNTHA
2000 IU
58394-0015-01
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
CABLIVI
11 MG
58468-0225-01
VIAL
COAGULANT VON WILLEBRAND FACTOR RECOMBINANT
SANOFI GENZYME
XYNTHA SOLOFUSE
3000 IU
58394-0016-03
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
VONVENDI
450 – 850 IU 00944-7551-02
VIAL
COAGULANT VON WILLEBRAND FACTOR RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
XYNTHA SOLOFUSE
1000 IU
58394-0024-03
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
VONVENDI
900 – 1700 IU 00944-7553-02
VIAL
COAGULANT VON WILLEBRAND FACTOR RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
XYNTHA SOLOFUSE
2000 IU
58394-0025-03
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
XYNTHA SOLOFUSE
250 IU
58394-0022-03
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
XYNTHA SOLOFUSE
500 IU
58394-0023-03
VIAL
COAGULANT
FACTOR VIII
RECOMBINANT
PFIZER, INC.
17
HG IMMUNOLOGY PRODUCTS - HYPERIMMUNE GLOBULIN Product Name Package Size NDC # Presentation Product Category Subcategory Derivation
Manufacturer
CYTOMEGALOVIRUS IMMUNE GLOBULIN
CYTOGAM
2.5 GRAMS 70257-0532-51
VIAL
HYPER IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
INTRAMUSCULAR IMMUNE GLOBULIN
GAMASTAN
2 ML
13533-0335-04
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMASTAN
10 ML
13533-0335-12
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HEPATITIS B IMMUNE GLOBULIN
HEPAGAM
5 ML
70257-0051-51
VIAL
HYPER IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
Simplify access to ASCENIV ™ & BIVIGAM ® for your patients When you decide that IVIG treatment is right for your patient, enroll them in the support program that can help connect them with potential financial assistance.
HEPAGAM
1 ML
70257-0052-51
VIAL
HYPER IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
HYPERHEP B
0.5ML VIAL
13533-0636-03
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERHEP B
1 ML VIAL
13533-0636-02
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERHEP B
5 ML VIAL
13533-0636-05
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
NABI-HB
1ML
69800-4202-01
VIAL
HYPER IMMUNE
IG
PLASMA
ADMA BIOLOGICS
NABI-HB
5ML
69800-4203-01
VIAL
HYPER IMMUNE
IG
PLASMA
ADMA BIOLOGICS
RABIES IMMUNE GLOBULIN
HYPERRAB
1 ML
13533-0318-01
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERRAB
3 ML
13533-0318-03
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERRAB
5 ML
13533-0318-05
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
ADMA ADvantage Ig TM is a dedicated patient support program created for eligible patients who have been prescribed ADMA Biologics treatment.
KEDRAB
2 ML
76125-0150-02
VIAL
SPECIALTY
IG
PLASMA
KEDRION BIOPHARMA
KEDRAB
10 ML
76125-0150-10
VIAL
SPECIALTY
IG
PLASMA
KEDRION BIOPHARMA
Comprehensive Support for Your Practice
Financial Assistance for Your Patients
Prescription Triage
Coverage and Reimbursement Support
TETANUS IMMUNE GLOBULIN
HYPERTET
250 IU
13533-0634-02
SYRINGE
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
VARICELLA ZOSTER IMMUNE GLOBULIN
VARIZIG
125 IU
70257-0126-51
VIAL
HYPER IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
RHO(D) IMMUNE GLOBULIN
HYPERRHO S/D FULL DOSE SYRINGE HYPERRHO S/D FULL DOSE SYRINGE 10PK HYPERRHO S/D MINI-DOSE SYRINGE 10PK
SINGLE
13533-0631-02
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
10 PACK
13533-0631-11
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
Enroll Your Patients Today!
10 PACK
13533-0661-06
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
MICRHOGAM
1 PACK
00562-7806-01
SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
RHOGAM
1 PACK
00562-7805-01
SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
Click here for the ASCENIV Enrollment Form
Click here for the BIVIGAM Enrollment Form
RHOGAM
5 PACK
00562-7805-05
SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
RHOGAM
25 PACK
00562-7805-25
SYRINGE PACK, 10 SYRINGES
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
© 2022 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics.
RHOPHYLAC
300 MCG 44206-0300-10
RH IMMUNE
IG
PLASMA
CSL BEHRING LLC
BIVIGAM ® is a registered trademark of ADMA Biologics. ADvantage Ig TM is a trademark of ADMA Biologics. Visit admabiologics.com
19
HG IMMUNOLOGY PRODUCTS - HYPERIMMUNE GLOBULIN Product Name Package Size NDC # Presentation Product Category Subcategory Derivation
IG IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC # Presentation Product Category Subcate- gory Derivation
Manufacturer
Manufacturer
1000 UG (5000 IU) 300 UG (1500 IU) 500 UG (2500 IU)
GAMUNEX
5 GRAM 13533-0800-20
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
WINRHO
70257-0310-51
VIAL
RH IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
GAMUNEX
20 GRAM 13533-0800-24
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
WINRHO
70257-0330-51
VIAL
RH IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
GAMUNEX
40 GRAM 13533-0800-40
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
WINRHO
70257-0350-51
VIAL
RH IMMUNE
IG
PLASMA
SAOL THERAPEUTICS, INC.
GAMUNEX
10 GRAM 13533-0800-71
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
OCTAGAM 10%
10% 2 GRAM 68982-0850-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
IG IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC # Presentation Product Category Subcate- gory Derivation
OCTAGAM 10%
10% 5 GRAM 68982-0850-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
OCTAGAM 10%
10% 10 GRAM 68982-0850-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
Manufacturer
OCTAGAM 10%
10% 20 GRAM 68982-0850-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
INTRAVENOUS IMMUNE GLOBULIN
OCTAGAM 10%
10% 30 GRAM 68982-0850-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
OCTAGAM 5%
5% 1 GRAM 68982-0840-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
ASCENIV
5 GRAM 69800-0250-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
OCTAGAM 5%
5% 2.5 GRAM 68982-0840-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
BIVIGAM
5 GRAM 69800-6502-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
OCTAGAM 5%
5% 5 GRAM 68982-0840-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
BIVIGAM
10 GRAM 69800-6503-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
OCTAGAM 5%
5% 10 GRAM 68982-0840-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
GAMMAGARD - LIQUID
1 GRAM 00944-2700-02
VIAL
IVIG
IG
PLASMA
PANZYGA
2.5 GRAM 00069-1109-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID
2.5 GRAM 00944-2700-03
VIAL
IVIG
IG
PLASMA
PANZYGA
5 GRAM 00069-1224-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
PANZYGA
10 GRAM 00069-1312-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID
5 GRAM 00944-2700-04
VIAL
IVIG
IG
PLASMA
PANZYGA
20 GRAM 00069-1415-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID
10 GRAM 00944-2700-05
VIAL
IVIG
IG
PLASMA
PANZYGA
30 GRAM 00069-1558-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
PANZYGA
2.5 GRAM 68982-0820-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - LIQUID
20 GRAM 00944-2700-06
VIAL
IVIG
IG
PLASMA
PANZYGA
5 GRAM 68982-0820-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - LIQUID
30 GRAM 00944-2700-07
VIAL
IVIG
IG
PLASMA
PANZYGA
10 GRAM 68982-0820-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
PANZYGA
20 GRAM 68982-0820-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - S/D
5 GRAM 00944-2656-03
VIAL
IVIG
IG
PLASMA
PANZYGA
30 GRAM 68982-0820-06
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - S/D
10 GRAM 00944-2658-04
VIAL
IVIG
IG
PLASMA
PRIVIGEN
5 GRAM 44206-0436-05
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
1 GRAM 76125-0900-01
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
10 GRAM 44206-0437-10
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
10 GRAM 76125-0900-10
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
20 GRAM 44206-0438-20
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
20 GRAM 76125-0900-20
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
40 GRAM 44206-0439-40
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
5 GRAM 76125-0900-50
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
SUBCUTANEOUS IMMUNE GLOBULIN
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
GAMMAPLEX 10%
10% 5 GRAM 64208-8235-05
VIAL
IVIG
IG
PLASMA
CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG HIZENTRA
1 GRAM 00069-1061-02 2 GRAM 00069-1476-02 4 GRAM 00069-1509-02 8 GRAM 00069-1965-02 1 GRAM 68982-0810-01 2 GRAM 68982-0810-03 4 GRAM 68982-0810-05 8 GRAM 68982-0810-06 1 GRAM 44206-0451-01
VIAL VIAL VIAL VIAL VIAL VIAL VIAL VIAL VIAL
SUBQ SUBQ SUBQ SUBQ
IG IG IG IG IG IG IG IG IG
PLASMA PLASMA PLASMA PLASMA PLASMA PLASMA PLASMA PLASMA PLASMA
PFIZER, INC. PFIZER, INC. PFIZER, INC. PFIZER, INC.
GAMMAPLEX 10%
10% 10 GRAM 64208-8235-06
VIAL
IVIG
IG
PLASMA
GAMMAPLEX 10%
10% 20 GRAM 64208-8235-07
VIAL
IVIG
IG
PLASMA
GAMMAPLEX 5%
5% 5 GRAM 64208-8234-06
VIAL
IVIG
IG
PLASMA
IVIG IVIG IVIG IVIG
OCTAPHARMA USA OCTAPHARMA USA OCTAPHARMA USA OCTAPHARMA USA CSL BEHRING LLC
GAMMAPLEX 5%
5% 10 GRAM 64208-8234-07
VIAL
IVIG
IG
PLASMA
GAMMAPLEX 5%
5% 20 GRAM 64208-8234-08
VIAL
IVIG
IG
PLASMA
GAMUNEX
1 GRAM 13533-0800-12
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
SUBQ
GAMUNEX
2.5 GRAM 13533-0800-15
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
21
Page 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16-17 Page 18-19 Page 20-21 Page 22-23 Page 24-25 Page 26-27 Page 28-29 Page 30Powered by FlippingBook